Skip to main content
Beovu (Brolucizumab) - Patient Guide to Therapy - for patients with visual impairment due to DMO
Beovu (Brolucizumab) - Patient Guide to Therapy - for patients with visual impairment due to DMO
Back to top
Risk Minimisation Materials
Search by company, common medicine name, or title of Risk Minimisation Material
Beovu
Novartis Pharmaceuticals UK Ltd
Beovu (Brolucizumab) - Patient Guide to Therapy - for patients with visual impairment due to wet AMD
Beovu (Brolucizumab) - Patient Guide to Therapy - for patients with visual impairment due to wet AMD
You are trying to reach document intended for healthcare professionals only.
Are you a healthcare professional?
